Mechanisms of Peripheral Tolerance Induction
外周耐受诱导机制
基本信息
- 批准号:6999624
- 负责人:
- 金额:$ 4.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The induction of immune tolerance is critical for the prevention of autoreactivity and subsequent autoimmune disease. Although several systems have been developed in the past to evaluate peripheral tolerance, the mechanisms by which this occurs remain largely undefined. The goal of the studies described in this proposal aim to understand the basic mechanisms of tolerance induction. Initially, the duration of antigen required to induce peripheral tolerance will be evaluated. This will be analyzed using an exciting new system of inducible expression, in which the model antigen, chicken ovalbumin (Ova), which contains the class I H- 2b restricted epitope, Ova257-264 (SIINFEKL), can be directly controlled. Thus it will be possible to temporally regulate Ova expression and determine the duration of antigen expression for tolerance induction as well as the longevity of tolerance once established. Further, we will expand on this model by generating additional transgenic animals that express altered peptide ligands of Ova257-264 with reduced abilities to stimulate T cells. This will allow us to evaluate how the strength of signal will influence the type and extent of peripheral tolerance. Together these studies will promote a better understanding of peripheral tolerance induction to developmentally and tissue specific antigens and the development of autoimmunity.
描述(由申请方提供):诱导免疫耐受对于预防自身反应性和随后的自身免疫性疾病至关重要。尽管过去已经开发了几种系统来评估外周耐受性,但其发生的机制在很大程度上仍不明确。本提案中描述的研究目标旨在了解耐受诱导的基本机制。最初,将评价诱导外周耐受所需的抗原持续时间。这将使用一个令人兴奋的新的诱导表达系统进行分析,其中模型抗原,鸡卵清蛋白(Ova),其中包含I类H- 2b限制性表位,Ova 257 -264(SIINFEKL),可以直接控制。因此,将有可能暂时调节Ova表达并确定用于耐受诱导的抗原表达的持续时间以及一旦建立耐受的寿命。此外,我们将通过产生额外的转基因动物来扩展该模型,这些转基因动物表达Ova 257 -264的改变的肽配体,其刺激T细胞的能力降低。这将使我们能够评估信号强度如何影响外周耐受的类型和程度。总之,这些研究将促进更好地了解外周耐受诱导发育和组织特异性抗原和自身免疫的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL J TURNER其他文献
MICHAEL J TURNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL J TURNER', 18)}}的其他基金
相似海外基金
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 4.4万 - 项目类别:
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 4.4万 - 项目类别:
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation
造血干细胞移植后过继性 T 淋巴细胞注射用于慢性诺如病毒治疗
- 批准号:
10459246 - 财政年份:2020
- 资助金额:
$ 4.4万 - 项目类别:
Utilizing intranasal immunization to induce a cytotoxic T lymphocyte response and reduce metastatic burden in the lung
利用鼻内免疫诱导细胞毒性 T 淋巴细胞反应并减少肺转移负担
- 批准号:
10090666 - 财政年份:2020
- 资助金额:
$ 4.4万 - 项目类别:
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation
造血干细胞移植后过继性 T 淋巴细胞注射用于慢性诺如病毒治疗
- 批准号:
10621950 - 财政年份:2020
- 资助金额:
$ 4.4万 - 项目类别:
Mechanisms of cross-presenting antigens in phagosomes on MHC I molecules to stimulate CD8 T lymphocyte responses
MHC I分子上的吞噬体中交叉呈递抗原刺激CD8 T淋巴细胞反应的机制
- 批准号:
9797712 - 财政年份:2019
- 资助金额:
$ 4.4万 - 项目类别:
Mechanisms of cross-presenting antigens in phagosomes on MHC I molecules to stimulate CD8 T lymphocyte responses
MHC I分子上的吞噬体中交叉呈递抗原刺激CD8 T淋巴细胞反应的机制
- 批准号:
10392945 - 财政年份:2019
- 资助金额:
$ 4.4万 - 项目类别: